HomeOpen Access NewsPharma

Pharma

Subscribe to Updates

Rapid test trial to diagnose winter respiratory infections in minutes

Pharma
NIHR-supported trial tests a rapid, low-cost point-of-care test that can diagnose flu, COVID‑19, and RSV in minutes, potentially speeding up winter diagnosis and care across the NHS.

Benchmarking Regulatory systems governing veterinary medicines

Pharma
Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.

Pharmaceuticals: Falsified medicines

Pharma
Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.

Why are illegal pharma markets still prevalent today?

Pharma
Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.

Cannabidiol, skin homeostasis and acne

Pharma
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.

The UK’s legalisation of medicinal cannabis

Pharma
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.

COVID-19 and drugs in the European neighbourhood partnership countries

Pharma
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.

Medical cannabis in the UK and the industry’s future

Pharma
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.

Drug prices in the U.S. are 2.56 times higher

Pharma
Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.

Antibiotics provide no benefit to COVID-19 patients

Pharma
The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.

Ivermectin effective in reducing mild COVID-19

Pharma
A new study has found that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19.

EU finalises talks with Valneva to secure a new vaccine

Pharma
Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.

Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine

Pharma
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.

Functionality of Hemp Proteins and their Peptides

Pharma
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.

CBD oil and cancer: What the research shows

Pharma
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.

Can we live without pharmacology?

Pharma
Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.

Antimicrobial resistance (AMR): A global health concern

Pharma
SACIDS Africa Centre of Excellence for Infectious Diseases trains young African scientists in research on global health issues: An example of a PhD Student Research on antimicrobial resistance (AMR).
1...8910Page 11 of 10

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd